Cheng Cheng
19Patents
3h-index
60Co-inventors
59Inventor score
Filing activity: Jan 19, 2006 → Oct 3, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10961283B2 | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens | Chemistry; Metallurgy | 6 | Active |
| US9526777B2 | Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein | Chemistry; Metallurgy | 6 | Active |
| US7638318B2 | Seneca Valley virus based compositions and methods for treating disease | Physics | 3 | Active |
| US10400015B2 | Recombinant HIV-1 envelope proteins and their use | Physics | 3 | Active |
| US11306341B2 | Methods of culturing a mammalian cell | Chemistry; Metallurgy | 2 | Active |
| US11459360B2 | Recombinant HIV-1 envelope proteins and their use | Physics | 2 | Active |
| US8039606B2 | Seneca Valley virus based compositions and methods for treating disease | Chemistry; Metallurgy | 2 | Active |
| US11939356B2 | Self-assembling insect ferritin nanoparticles | Chemistry; Metallurgy | 1 | Active |
| US8753622B2 | Seneca valley virus based compositions and methods for treating disease | Physics | 1 | Active |
| US11136356B2 | Recombinant HIV-1 envelope proteins and their use | Chemistry; Metallurgy | 0 | Active |
| US11820836B2 | Polypeptide and use thereof | Human Necessities | 0 | Active |
| US11235056B2 | Glycan-masked engineered outer domains of HIV-1 gp120 and their use | Chemistry; Metallurgy | 0 | Active |
| US10584355B2 | Chimpanzee adenoviral vector-based filovirus vaccines | Chemistry; Metallurgy | 0 | Active |
| US11390647B2 | Polypeptide and use thereof | Human Necessities | 0 | Active |
| US11602559B2 | HIV-1 Env fusion peptide immunogens and their use | Chemistry; Metallurgy | 0 | Active |
| US12053520B2 | Glycan-masked engineered outer domains of HIV-1 gp120 and their use | Chemistry; Metallurgy | 0 | Active |
| US12145968B2 | Recombinant HIV-1 envelope proteins and their use | Physics | 0 | Active |
| US9701718B2 | Adenovirus serotype 26 and serotype 35 filovirus vaccines | Chemistry; Metallurgy | 0 | Active |
| US11913013B2 | Chimpanzee adenoviral vector-based filovirus vaccines | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.